Moody's Corporation
MCO - NYSE - $455.91 ▲ +%1.41
-
Earnings Wed 22 Jul

Moody's opens the
books on Wednesday evening.

13 analysts' median target is $538[FMP target], stock is $456, +17.9% upside potential. After Q1 +2.6% EPS beat[FMP earnings], the stock moved -3.1%.

summary below
Quick Take - in 40 seconds
B
BUY Council 3/6 - Moonshot 61

B = MoonshotScore 61[9-pillar formula] + Council 3/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $2.1B[FMP est], EPS $4.19[FMP est]. 8 consecutive quarters of beat[FMP earnings].

$4.19 EPS Estimate Last year $3.64 - +18% YoY YoY
8 Beat Streak Expectations beaten consecutively for the last 8 quarters

Q1 EPS +2.6% beat[FMP] but the stock -3.1% D+1[FMP D+1]. Noemie Heuland promised $95.0M CapEx + a sequential decline in Q4 during the Q1 earnings call[Noemie Heuland capex transcript].

Watchlist

5 metrics stand out this quarter.

80% Investor Focus

Private Credit Growth

private_credit_growth

As private market scale and come under greater scrutiny, demand for our independent credit assessment continues to increase, and that dynamic contributed to private credit related revenue in Ratings growing more than 80% year-over-year.

"Private credit activity remained durable this quarter despite increasing credit concerns. As private market scale and come under greater scrutiny, demand for our independent credit assessment continues to increase, and that dynamic contributed to private credit related revenue in Ratings growing more than 80% year-over-year."

- Robert Fauber, CEO - Q1 FY26 Earnings Call - April 22, 2026
18% Investor Focus

Lending Suite Growth

lending_suite_growth

Our AI-enabled lending suite continues to gain traction as banks modernize end-to-end credit workflows, and ARR for our lending suite grew 18% year-over-year.

"And our AI-enabled lending suite continues to gain traction as banks modernize end-to-end credit workflows. ARR for our lending suite grew 18% year-over-year, was driven by customers upgrading to an integrated platform that spans origination, decisioning and monitoring."

- Robert Fauber, CEO - Q1 FY26 Earnings Call - April 22, 2026
11% Investor Focus

Recurring Revenue Shift

recurring_revenue_shift

Recurring revenue at Moody's Analytics (MA) represented 98% of total MA revenue, underscoring a shift towards renewable subscription-based solutions.

"Recurring revenue grew 11% as reported or 7% on an organic constant currency basis and represented 98% of total MA revenue underscoring the shift towards renewable subscription-based solutions."

- Noemie Heuland - Q1 FY26 Earnings Call - April 22, 2026
8% Investor Focus

Ma Revenue Growth

ma_revenue_growth

Moody's Analytics (MA) revenue increased by 8%, supported by the strength of recurring revenues.

"MA revenue increased 8% in the first quarter as reported or 6% on an organic constant currency basis, reflecting healthy underlying demand across our core franchises."

- Noemie Heuland - Q1 FY26 Earnings Call - April 22, 2026
33% Investor Focus

Investment Grade Growth

investment_grade_growth

Investment grade issuance increased significantly, driven by a record first quarter in corporate finance, particularly from hyperscalers and other technology issuers.

"Investment grade was the largest contributor with revenue up 33% year-over-year. Investment grade revenue within Corporate Finance was driven by a record first quarter and the second highest quarter ever for issuance, including several jumbo transactions from hyperscalers and other technology issuers."

- Noemie Heuland - Q1 FY26 Earnings Call - April 22, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +17.9%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 53
Klarman value - target upside +17.9%
Buffett quality - ROE score 5/5
Munger valuation - target upside +17.9%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
52.9 RSI 52.9 balanced, 50d above
MACD
+1.60 price above 50d - support positive
50d MA
$449 stock 1.6% above - short-term support
200d MA
$483 stock 5.6% below - long-term pressure
Volume (10d)
-91% decrease - low participation
Resistance
$538
Analyst median target - upgrade trigger if broken
Current
$456
Pre-earnings position
Support
$411
Invalidation - close below this is a technical breakdown
Pattern
Range
$411-$538 band - earnings breakout/breakdown trigger

Past Performance

Moody's beat expectations in the last 8 quarters.

BEAT
Q2 FY25
$3.56 vs $3.39 est - +1.0%
BEAT
Q3 FY25
$3.92 vs $3.70 est - +1.4%
BEAT
Q4 FY25
$3.64 vs $3.43 est - -0.3%
BEAT
Q1 FY26
$4.33 vs $4.22 est - -3.1%

Q1 (April 22, 2026): EPS $4.33 vs $4.22 est[FMP], +2.6% beat. D+1 movement: -3.1%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $4.06 (no guidance)

Q1: EPS $4.33 vs $4.22 beat[FMP], stock -3.1% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $95.0M[FMP cashflow]. Q1 op margin 44.3%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $4.19 + CapEx discipline
Threshold: EPS > $4.19[FMP est].
Target: Break above median target $538[FMP target]; high target $610[FMP] upper bound.
Scenario B - In-Line
EPS approx $4.19 + CapEx < $95.0M
Threshold: EPS approx $4.19[FMP est], Q4 CapEx < $95.0M[FMP].
Target: Consolidation in the band between current $456[FMP] and median $538[FMP].
Scenario C - Miss
EPS < $4.06 or CapEx >= $95.0M
Threshold: EPS < $4.06[FMP estx0.97].
Target: Current $456 below SMA200 $483[FMP], if rejection continues, $411[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 13 analysts say?

Wall Street Consensus
$538
12-month median target price (+17.9% upside potential)
16
BUY
7
HOLD
0
SELL
Risk Management
$411
Invalidation level - critical support threshold
$449 - 50-day MA (above, +1.6%)
$483 - 200-day MA (below, -5.6%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - MCO Q4 FY26
B

You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Wednesday evening. The framework is ready on this page: Q4 EPS threshold $4.19[FMP], CapEx threshold "below $95.0M"[Noemie Heuland]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 22, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 23, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 5, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 22, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the MCO earnings preview cover?

This MCO (MCO) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in MCO earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.